The 12-Month Price Target For LENZ Therapeutics Inc. (NASDAQ:LENZ) Is Now 36.
In last trading session, LENZ Therapeutics Inc. (NASDAQ:LENZ) saw 0.4 million shares changing hands with its beta currently measuring 0.48. Company’s recent per share price